140 related articles for article (PubMed ID: 8589298)
1. Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics.
Welage LS; Mason NA; Hoffman EJ; Odeh RM; Dombrouski J; Patel JA; Swartz RD
J Am Soc Nephrol; 1995 Oct; 6(4):1284-90. PubMed ID: 8589298
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
Mason NA; Neudeck BL; Welage LS; Patel JA; Swartz RD
Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
[TBL] [Abstract][Full Text] [Related]
3. Effects of dialysis membrane on intradialytic vancomycin administration.
Scott MK; Macias WL; Kraus MA; Clark WR; Carfagna MA; Mueller BA
Pharmacotherapy; 1997; 17(2):256-62. PubMed ID: 9085316
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.
DeSoi CA; Sahm DF; Umans JG
Am J Kidney Dis; 1992 Oct; 20(4):354-60. PubMed ID: 1415203
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin mass transfer characteristics of high-flux cellulosic dialysers.
Scott MK; Mueller BA; Clark WR
Nephrol Dial Transplant; 1997 Dec; 12(12):2647-53. PubMed ID: 9430866
[TBL] [Abstract][Full Text] [Related]
6. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease.
Touchette MA; Patel RV; Anandan JV; Dumler F; Zarowitz BJ
Am J Kidney Dis; 1995 Sep; 26(3):469-74. PubMed ID: 7645555
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
Torras J; Cao C; Rivas MC; Cano M; Fernandez E; Montoliu J
Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
[TBL] [Abstract][Full Text] [Related]
10. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
Allawati H; Dallas L; Nair S; Palmer J; Thaikandy S; Hutchison C
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32408589
[TBL] [Abstract][Full Text] [Related]
11. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers.
Thalhammer F; Kletzmayr J; El Menyawi I; Kovarik J; Rosenkranz AR; Traunmüller F; Hörl WH; Burgmann H
Am J Kidney Dis; 1998 Oct; 32(4):642-5. PubMed ID: 9774127
[TBL] [Abstract][Full Text] [Related]
12. Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers.
Sowinski KM; Mueller BA; Grabe DW; Manley HJ; Frye RF; Bailie GR; Marx MA
Am J Kidney Dis; 2001 Apr; 37(4):766-76. PubMed ID: 11273877
[TBL] [Abstract][Full Text] [Related]
13. Effects of Plasma Proteins on the Transport and Surface Characteristics of Polysulfone/Polyethersulfone and Asymmetric Cellulose Triacetate High Flux Dialyzers.
Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
Artif Organs; 2018 Nov; 42(11):1070-1077. PubMed ID: 29774568
[TBL] [Abstract][Full Text] [Related]
14. Rebound kinetics of beta2-microglobulin after hemodialysis.
Leypoldt JK; Cheung AK; Deeter RB
Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
[TBL] [Abstract][Full Text] [Related]
15. CAHP-210 dialyzer influence on intra-dialytic vancomycin removal.
Lucksiri A; Scott MK; Mueller BA; Hamburger RJ; Sowinski KM
Nephrol Dial Transplant; 2002 Sep; 17(9):1649-54. PubMed ID: 12198218
[TBL] [Abstract][Full Text] [Related]
16. Removal of vancomycin by high-flux hemodialysis membranes.
Quale JM; O'Halloran JJ; DeVincenzo N; Barth RH
Antimicrob Agents Chemother; 1992 Jul; 36(7):1424-6. PubMed ID: 1510437
[TBL] [Abstract][Full Text] [Related]
17. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
McCarthy JT; Jenson BM; Squillace DP; Williams AW
Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
[TBL] [Abstract][Full Text] [Related]
18. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
Ariano RE; Fine A; Sitar DS; Rexrode S; Zelenitsky SA
Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of three haemodialysis membranes on vancomycin disposition.
Alwakeel J; Najjar TA; al-Yamani MJ; Huraib S; al-Haider A; Abu-aisha H
Int Urol Nephrol; 1994; 26(2):223-8. PubMed ID: 8034435
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
Rider TR; Silinskie KM; Hite MS; Bress J
Pharmacotherapy; 2020 Oct; 40(10):1036-1041. PubMed ID: 32866291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
